{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:12:02Z","timestamp":1794435122903,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","award":["POR Regione Campania Covid-19"],"award-info":[{"award-number":["POR Regione Campania Covid-19"]}],"id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MUR","award":["PRIN 2022-MUR Italy"],"award-info":[{"award-number":["PRIN 2022-MUR Italy"]}]},{"name":"MUR","award":["Grant 20224NCSN5 (PreMeRetHOn)"],"award-info":[{"award-number":["Grant 20224NCSN5 (PreMeRetHOn)"]}]},{"name":"PNRR","award":["PNRR-CN3 National Center for Gene Therapy and Drugs based on RNA Technology"],"award-info":[{"award-number":["PNRR-CN3 National Center for Gene Therapy and Drugs based on RNA Technology"]}]},{"name":"CEINGE","award":["CEINGE TASK-FORCE-2022 COVID 19\u201d CUP D63C22000570002"],"award-info":[{"award-number":["CEINGE TASK-FORCE-2022 COVID 19\u201d CUP D63C22000570002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Different innate immune pathways converge to Stimulator of interferon genes (STING) and trigger type I interferon responses after recognition of abnormal nucleic acids in the cells. This non-redundant function renders STING a major player in immunosurveillance, and an emerging target for cancer and infectious diseases therapeutics. Beyond somatic mutations that often occur in cancer, the human gene encoding STING protein,\n                    <jats:italic>TMEM173 (STING1)<\/jats:italic>\n                    , holds great genetic heterogeneity; R232, HAQ (R71H-G230A-R293Q) and H232 are the most common alleles. Although some of these alleles are likely to be hypomorphic, their function is still debated, due to the available functional assessments, which have been performed in biased biological systems. Here, by using genetic background-matched models, we report on the functional evaluation of R232, HAQ and H232 variants on STING function, and on how these genotypes affect the susceptibility to clinically relevant viruses, thus supporting a potential contributing cause to differences in inter-individual responses to infections. Our findings also demonstrate a novel toll-like receptor-independent role of STING in modulating monocytic cell function and differentiation into macrophages. We further supported the interplay of\n                    <jats:italic>STING1<\/jats:italic>\n                    variants and human biology by demonstrating how monocytes bearing the H232 allele were impaired in M1\/M2 differentiation, interferon response and antigen presentation. Finally, we assessed the response to PD-1 inhibitor in a small cohort of melanoma patients stratified according to STING genotype. Given the contribution of the STING protein in sensing DNA viruses, bacterial pathogens and misplaced cancer DNA, these data may support the development of novel therapeutic options for infectious diseases and cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-46830-5","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T13:01:44Z","timestamp":1699534904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties"],"prefix":"10.1038","volume":"13","author":[{"given":"Guendalina","family":"Froechlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Finizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Napolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Amiranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"2","key":"46830_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","volume":"19","author":"Z Ma","year":"2016","unstructured":"Ma, Z. & Damania, B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 19(2), 150\u2013158 (2016).","journal-title":"Cell Host Microbe"},{"issue":"6","key":"46830_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140(6), 805\u2013820 (2010).","journal-title":"Cell"},{"key":"46830_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2014.12.002","volume":"32","author":"IM Dambuza","year":"2015","unstructured":"Dambuza, I. M. & Brown, G. D. C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32, 21\u201327 (2015).","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"46830_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","volume":"38","author":"D Goubau","year":"2013","unstructured":"Goubau, D., Deddouche, S. & e Sousa, C. R. Cytosolic sensing of viruses. Immunity 38(5), 855\u201369 (2013).","journal-title":"Immunity"},{"issue":"6","key":"46830_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrmicro.2016.45","volume":"14","author":"YK Chan","year":"2016","unstructured":"Chan, Y. K. & Gack, M. U. Viral evasion of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 14(6), 360\u2013373 (2016).","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"46830_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00005-017-0481-7","volume":"66","author":"O Sokolowska","year":"2018","unstructured":"Sokolowska, O. & Nowis, D. STING Signaling in cancer cells: Important or not?. Arch. Immunol. Ther. Exp. (Warsz) 66(2), 125\u2013132 (2018).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"9","key":"46830_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","volume":"18","author":"S Skopelja-Gardner","year":"2022","unstructured":"Skopelja-Gardner, S., An, J. & Elkon, K. B. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nat. Rev. Nephrol. 18(9), 558\u2013572 (2022).","journal-title":"Nat. Rev. Nephrol."},{"issue":"22","key":"46830_CR8","doi-asserted-by":"publisher","first-page":"14232","DOI":"10.3390\/ijms232214232","volume":"23","author":"C Caiazza","year":"2022","unstructured":"Caiazza, C. et al. The lack of STING impairs the MHC-I dependent antigen presentation and JAK\/STAT signaling in murine macrophages. Int. J. Mol. Sci. 23(22), 14232 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"46830_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/21645515.2017.1395995","volume":"14","author":"T Ohkuri","year":"2018","unstructured":"Ohkuri, T. et al. Effects of STING stimulation on macrophages: STING agonists polarize into \u201cclassically\u201d or \u201calternatively\u201d activated macrophages?. Hum. Vaccin. Immunother. 14(2), 285\u2013287 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"46830_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41435-018-0029-9","volume":"20","author":"S Patel","year":"2019","unstructured":"Patel, S. & Jin, L. TMEM173 variants and potential importance to human biology and disease. Genes Immun. 20(1), 82\u201389 (2019).","journal-title":"Genes Immun."},{"issue":"2","key":"46830_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/ijms22020477","volume":"22","author":"G Froechlich","year":"2021","unstructured":"Froechlich, G. et al. Generation of a novel mesothelin-targeted oncolytic herpes virus and implemented strategies for manufacturing. Int. J. Mol. Sci. 22(2), 477 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"46830_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/gene.2010.75","volume":"12","author":"L Jin","year":"2011","unstructured":"Jin, L. et al. Identification and characterization of a loss-of-function human MPYS variant. Genes Immun. 12(4), 263\u2013269 (2011).","journal-title":"Genes Immun."},{"issue":"10","key":"46830_CR13","doi-asserted-by":"publisher","first-page":"e77846","DOI":"10.1371\/journal.pone.0077846","volume":"8","author":"G Yi","year":"2013","unstructured":"Yi, G. et al. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLOS ONE 8(10), e77846 (2013).","journal-title":"PLOS ONE"},{"issue":"11","key":"46830_CR14","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.4049\/jimmunol.1700322","volume":"198","author":"S Patel","year":"2017","unstructured":"Patel, S. et al. Response to comment on \u201cthe common R71H\u2013G230A-R293Q human TMEM173 is a null allele\u201d. J. Immunol. 198(11), 4185\u20134188 (2017).","journal-title":"J. Immunol."},{"issue":"11","key":"46830_CR15","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.4049\/jimmunol.1700294","volume":"198","author":"KE Sivick","year":"2017","unstructured":"Sivick, K. E. et al. Comment on \u201cthe common R71H\u2013G230A-R293Q human TMEM173 is a null allele\u201d. J. Immunol. 198(11), 4183\u20134185 (2017).","journal-title":"J. Immunol."},{"issue":"1","key":"46830_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cas.14680","volume":"112","author":"JM Lubbers","year":"2021","unstructured":"Lubbers, J. M. et al. Association of homozygous variants of STING1 with outcome in human cervical cancer. Cancer Sci. 112(1), 61\u201371 (2021).","journal-title":"Cancer Sci."},{"key":"46830_CR17","doi-asserted-by":"publisher","first-page":"567348","DOI":"10.3389\/fimmu.2020.567348","volume":"11","author":"RB Kennedy","year":"2020","unstructured":"Kennedy, R. B. et al. Polymorphisms in STING affect human innate immune responses to poxviruses. Front. Immunol. 11, 567348 (2020).","journal-title":"Front. Immunol."},{"issue":"11","key":"46830_CR18","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3390\/cancers13112695","volume":"13","author":"A Amouzegar","year":"2021","unstructured":"Amouzegar, A. et al. STING agonists as cancer therapeutics. Cancers (Basel) 13(11), 2695 (2021).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"46830_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales, L. et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 11(7), 1018\u20131030 (2015).","journal-title":"Cell Rep."},{"key":"46830_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.omtn.2018.11.003","volume":"14","author":"X An","year":"2019","unstructured":"An, X. et al. An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in pan-cancer. Mol. Ther. Nucleic Acids 14, 80\u201389 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"15","key":"46830_CR21","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","volume":"37","author":"H Konno","year":"2018","unstructured":"Konno, H. et al. Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene 37(15), 2037\u20132051 (2018).","journal-title":"Oncogene"},{"issue":"22","key":"46830_CR22","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","volume":"76","author":"T Xia","year":"2016","unstructured":"Xia, T., Konno, H. & Barber, G. N. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis. Cancer Res. 76(22), 6747\u20136759 (2016).","journal-title":"Cancer Res."},{"issue":"4","key":"46830_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/1541-7786.MCR-18-0504","volume":"17","author":"N de Queiroz","year":"2019","unstructured":"de Queiroz, N. et al. Ovarian cancer cells commonly exhibit defective STING signaling which affects sensitivity to viral oncolysis. Mol. Cancer Res. 17(4), 974\u2013986 (2019).","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"46830_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jtho.2020.01.009","volume":"15","author":"CM Della Corte","year":"2020","unstructured":"Della Corte, C. M. et al. STING pathway expression identifies NSCLC with an immune-responsive phenotype. J. Thorac. Oncol. 15(5), 777\u2013791 (2020).","journal-title":"J. Thorac. Oncol."},{"issue":"49","key":"46830_CR25","doi-asserted-by":"publisher","first-page":"e2214278119","DOI":"10.1073\/pnas.2214278119","volume":"119","author":"YT Wu","year":"2022","unstructured":"Wu, Y. T. et al. Tumor-targeted delivery of a STING agonist improvescancer immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 119(49), e2214278119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"46830_CR26","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jso.26804","volume":"125","author":"Z Lohinai","year":"2022","unstructured":"Lohinai, Z. et al. Loss of STING expression is prognostic in non-small cell lung cancer. J. Surg. Oncol. 125(6), 1042\u20131052 (2022).","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"46830_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S Tsuchiya","year":"1980","unstructured":"Tsuchiya, S. et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26(2), 171\u2013176 (1980).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"46830_CR28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.celrep.2013.05.009","volume":"3","author":"EJ Diner","year":"2013","unstructured":"Diner, E. J. et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3(5), 1355\u20131361 (2013).","journal-title":"Cell Rep."},{"key":"46830_CR29","doi-asserted-by":"publisher","first-page":"101206","DOI":"10.1016\/j.coviro.2022.101206","volume":"53","author":"LG Webb","year":"2022","unstructured":"Webb, L. G. & Fernandez-Sesma, A. RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing. Curr. Opin. Virol. 53, 101206 (2022).","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"46830_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.it.2016.12.004","volume":"38","author":"A Zevini","year":"2017","unstructured":"Zevini, A., Olagnier, D. & Hiscott, J. Crosstalk between Cytoplasmic RIG-I and STING sensing pathways. Trends Immunol. 38(3), 194\u2013205. https:\/\/doi.org\/10.1016\/j.it.2016.12.004 (2017).","journal-title":"Trends Immunol."},{"issue":"20","key":"46830_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.01015-18","volume":"92","author":"S Pan","year":"2018","unstructured":"Pan, S. et al. Herpes simplex virus 1 gamma(1)345 protein inhibits STING activation that restricts viral replication. J. Virol. 92(20), 10\u20131128 (2018).","journal-title":"J. Virol."},{"key":"46830_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.omto.2020.10.006","volume":"19","author":"M De Lucia","year":"2020","unstructured":"De Lucia, M. et al. Retargeted and multi-cytokine-armed herpes virus is a potent cancer endovaccine for local and systemic anti-tumor treatment. Mol. Ther. Oncolytics 19, 253\u2013264 (2020).","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"46830_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12985-020-01481-0","volume":"17","author":"W Zheng","year":"2020","unstructured":"Zheng, W. et al. Correction to: Toll-like receptor-mediated innate immunity against herpesviridae infection: A current perspective on viral infection signaling pathways. Virol. J. 17(1), 199 (2020).","journal-title":"Virol. J."},{"key":"46830_CR34","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.smim.2020.101430","volume":"50","author":"E Sasso","year":"2020","unstructured":"Sasso, E. et al. New viral vectors for infectious diseases and cancer. Semin. Immunol. 50, 101430 (2020).","journal-title":"Semin. Immunol."},{"key":"46830_CR35","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302059","author":"Burkart","year":"2023","unstructured":"Burkart, et al. High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response. Life Sci. Alliance https:\/\/doi.org\/10.26508\/lsa.202302059 (2023).","journal-title":"Life Sci. Alliance"},{"issue":"6","key":"46830_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00262-017-1975-1","volume":"66","author":"T Ohkuri","year":"2017","unstructured":"Ohkuri, T. et al. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. Cancer Immunol. Immunother. 66(6), 705\u2013716 (2017).","journal-title":"Cancer Immunol. Immunother."},{"key":"46830_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3389\/fimmu.2017.01097","volume":"8","author":"F Raggi","year":"2017","unstructured":"Raggi, F. et al. Regulation of human macrophage M1\u2013M2 polarization balance by hypoxia and the triggering receptor expressed on myeloid cells-1. Front. Immunol. 8, 1097 (2017).","journal-title":"Front. Immunol."},{"issue":"3","key":"46830_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2249.2004.02624.x","volume":"138","author":"S Marckmann","year":"2004","unstructured":"Marckmann, S. et al. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis. Clin. Exp. Immunol. 138(3), 499\u2013506 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"46830_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fimmu.2013.00397","volume":"4","author":"A Neerincx","year":"2013","unstructured":"Neerincx, A. et al. NLRC5, at the heart of antigen presentation. Front. Immunol. 4, 397 (2013).","journal-title":"Front. Immunol."},{"issue":"1","key":"46830_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy. Signal Transduct. Target. Ther. 7(1), 394 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"46830_CR41","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1021\/acs.jmedchem.9b01039","volume":"63","author":"H Zhang","year":"2020","unstructured":"Zhang, H., You, Q. D. & Xu, X. L. Targeting stimulator of interferon genes (STING): A medicinal chemistry perspective. J. Med. Chem. 63(8), 3785\u20133816 (2020).","journal-title":"J. Med. Chem."},{"issue":"1","key":"46830_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity 53(1), 115\u2013126 (2020).","journal-title":"Immunity"},{"issue":"1","key":"46830_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bpj.2017.10.027","volume":"114","author":"AY Shih","year":"2018","unstructured":"Shih, A. Y., Damm-Ganamet, K. L. & Mirzadegan, T. Dynamic structural differences between human and mouse STING lead to differing sensitivity to DMXAA. Biophys. J. 114(1), 32\u201339 (2018).","journal-title":"Biophys. J."},{"issue":"4","key":"46830_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.celrep.2019.03.098","volume":"27","author":"CC de Oliveira Mann","year":"2019","unstructured":"de Oliveira Mann, C. C. et al. Modular architecture of the STING C-terminal tail allows interferon and NF-kappaB signaling adaptation. Cell Rep. 27(4), 1165\u20131175 (2019).","journal-title":"Cell Rep."},{"issue":"12","key":"46830_CR45","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1021\/acs.jcim.2c00315","volume":"62","author":"J Morere","year":"2022","unstructured":"Morere, J. et al. How fragile we are: Influence of stimulator of interferon genes (STING) variants on pathogen recognition and immune response efficiency. J. Chem. Inf. Model. 62(12), 3096\u20133106 (2022).","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"46830_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam, F. et al. Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas. Clin. Cancer Res. 28(4), 677\u2013688 (2022).","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"46830_CR47","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.3390\/cancers12113407","volume":"12","author":"G Froechlich","year":"2020","unstructured":"Froechlich, G. et al. Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus. Cancers (Basel) 12(11), 3407 (2020).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"46830_CR48","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00262-022-03327-w","volume":"72","author":"JC Kim","year":"2023","unstructured":"Kim, J. C. et al. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity. Cancer Immunol. Immunother. 72(5), 1327\u20131335 (2023).","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"46830_CR49","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1021\/acs.jmedchem.1c02197","volume":"65","author":"W Chang","year":"2022","unstructured":"Chang, W. et al. Discovery of MK-1454: A potent cyclic dinucleotide stimulator of interferon genes agonist for the treatment of cancer. J. Med. Chem. 65(7), 5675\u20135689 (2022).","journal-title":"J. Med. Chem."},{"issue":"11","key":"46830_CR50","first-page":"1740","volume":"16","author":"DS Kim","year":"2021","unstructured":"Kim, D. S. et al. E7766, a macrocycle-bridged stimulator of interferon genes (STING) agonist with potent pan-genotypic activity. ChemMedChem 16(11), 1740\u20131743 (2021).","journal-title":"ChemMedChem"},{"issue":"9","key":"46830_CR51","doi-asserted-by":"publisher","first-page":"e002569","DOI":"10.1136\/jitc-2021-002569","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia. J. Immunother. Cancer 9(9), e002569 (2021).","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"46830_CR52","doi-asserted-by":"publisher","first-page":"eaa1713","DOI":"10.1126\/sciimmunol.aal1713","volume":"2","author":"P Dai","year":"2017","unstructured":"Dai, P. et al. Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells. Sci. Immunol. 2(11), eaa1713 (2017).","journal-title":"Sci. Immunol."},{"issue":"5","key":"46830_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ccell.2018.03.027","volume":"33","author":"J Ahn","year":"2018","unstructured":"Ahn, J. et al. Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Cancer Cell 33(5), 862\u2013873 (2018).","journal-title":"Cancer Cell"},{"issue":"5","key":"46830_CR54","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","volume":"29","author":"L Schadt","year":"2019","unstructured":"Schadt, L. et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 29(5), 1236\u20131248 (2019).","journal-title":"Cell Rep."},{"key":"46830_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2017.12.001","volume":"110","author":"RE Vatner","year":"2019","unstructured":"Vatner, R. E. & Janssen, E. M. STING, DCs and the link between innate and adaptive tumor immunity. Mol. Immunol. 110, 13\u201323 (2019).","journal-title":"Mol. Immunol."},{"issue":"20","key":"46830_CR56","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.1158\/1078-0432.CCR-17-0681","volume":"23","author":"AK Moesta","year":"2017","unstructured":"Moesta, A. K. et al. Local delivery of OncoVEXmGM-CSF generates systemic antitumor immune responses enhanced by cytotoxic T-lymphocyte\u2013associated protein blockade. Clin. Cancer Res. 23(20), 6190\u20136202 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"46830_CR57","doi-asserted-by":"publisher","first-page":"e028464","DOI":"10.1371\/journal.pone.0284645","volume":"18","author":"SS Withers","year":"2023","unstructured":"Withers, S. S. et al. Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells. PLOS ONE. 18(4), e028464 (2023).","journal-title":"PLOS ONE."},{"issue":"2","key":"46830_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","volume":"54","author":"RW Sayaman","year":"2021","unstructured":"Sayaman, R. W. et al. Germline genetic contribution to the immune landscape of cancer. Immunity 54(2), 367\u2013386 (2021).","journal-title":"Immunity"},{"issue":"16","key":"46830_CR59","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","volume":"30","author":"C Verheust","year":"2012","unstructured":"Verheust, C. et al. Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30(16), 2623\u20132632 (2012).","journal-title":"Vaccine"},{"issue":"4","key":"46830_CR60","doi-asserted-by":"publisher","first-page":"e1003989","DOI":"10.1371\/journal.ppat.1003989","volume":"10","author":"P Dai","year":"2014","unstructured":"Dai, P. et al. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS\/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog. 10(4), e1003989 (2014).","journal-title":"PLoS Pathog."},{"issue":"1","key":"46830_CR61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41541-022-00542-5","volume":"7","author":"N Yang","year":"2022","unstructured":"Yang, N. et al. Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant. NPJ Vaccin. 7(1), 120 (2022).","journal-title":"NPJ Vaccin."},{"key":"46830_CR62","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41417-023-00610-5","volume":"30","author":"S Riederer","year":"2023","unstructured":"Riederer, S. et al. Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease. Cancer Gene Ther. 30, 1029\u20131039 (2023).","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"46830_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41467-023-36212-w","volume":"14","author":"P Dhillon","year":"2023","unstructured":"Dhillon, P. et al. Increased levels of endogenous retroviruses trigger fibroinflammation and play a role in kidney disease development. Nat. Commun. 14(1), 559 (2023).","journal-title":"Nat. Commun."},{"issue":"82","key":"46830_CR64","doi-asserted-by":"publisher","first-page":"eade2860","DOI":"10.1126\/sciimmunol.ade2860","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Encephalitis and poor neuronal death\u2013mediated control of herpes simplex virus in human inherited RIPK3 deficiency. Sci. Immunol. 8(82), eade2860 (2023).","journal-title":"Sci. Immunol."},{"key":"46830_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12979-020-00176-y","volume":"17","author":"L Hamann","year":"2020","unstructured":"Hamann, L. et al. First evidence for STING SNP R293Q being protective regarding obesity-associated cardiovascular disease in age-advanced subjects: A cohort study. Immun. Ageing 17, 7 (2020).","journal-title":"Immun. Ageing"},{"issue":"2","key":"46830_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000492972","volume":"65","author":"L Hamann","year":"2019","unstructured":"Hamann, L. et al. STING SNP R293Q is associated with a decreased risk of aging-related diseases. Gerontology 65(2), 145\u2013154 (2019).","journal-title":"Gerontology"},{"issue":"1","key":"46830_CR67","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","volume":"11","author":"DS Leventhal","year":"2020","unstructured":"Leventhal, D. S. et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat. Commun. 11(1), 2739 (2020).","journal-title":"Nat. Commun."},{"issue":"11","key":"46830_CR68","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.4049\/jimmunol.2200158","volume":"209","author":"S Mansouri","year":"2022","unstructured":"Mansouri, S. et al. MPYS modulates fatty acid metabolism and immune tolerance at homeostasis independent of type I IFNs. J. Immunol. 209(11), 2114\u20132132 (2022).","journal-title":"J. Immunol."},{"key":"46830_CR69","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3389\/fimmu.2019.02770","volume":"10","author":"S Keskitalo","year":"2019","unstructured":"Keskitalo, S. et al. Novel TMEM173 mutation and the role of disease modifying alleles. Front. Immunol. 10, 2770. https:\/\/doi.org\/10.3389\/fimmu.2019.02770 (2019).","journal-title":"Front. Immunol."},{"issue":"21","key":"46830_CR70","doi-asserted-by":"publisher","first-page":"11080","DOI":"10.1128\/JVI.00954-15","volume":"89","author":"ZM Parker","year":"2015","unstructured":"Parker, Z. M., Murphy, A. A. & Leib, D. A. Role of the DNA sensor STING in protection from lethal infection following corneal and intracerebral challenge with herpes simplex virus 1. J. Virol. 89(21), 11080\u201311091. https:\/\/doi.org\/10.1128\/JVI.00954-15 (2015).","journal-title":"J. Virol."},{"key":"46830_CR71","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/mi.2015.124","volume":"9","author":"D Royer","year":"2016","unstructured":"Royer, D. & Carr, D. A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin. Mucosal Immunol. 9, 1065\u20131075. https:\/\/doi.org\/10.1038\/mi.2015.124 (2016).","journal-title":"Mucosal Immunol."},{"key":"46830_CR72","doi-asserted-by":"publisher","first-page":"674920","DOI":"10.1155\/2015\/674920","volume":"2015","author":"E Sasso","year":"2015","unstructured":"Sasso, E. et al. Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells. Biomed. Res. Int. 2015, 674920 (2015).","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"46830_CR73","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/s41598-020-61275-w","volume":"10","author":"E Sasso","year":"2020","unstructured":"Sasso, E. et al. Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis. Sci. Rep. 10(1), 4307 (2020).","journal-title":"Sci. Rep."},{"key":"46830_CR74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","volume":"4","author":"H Rehman","year":"2016","unstructured":"Rehman, H. et al. Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy. J. Immunother. Cancer 4, 53 (2016).","journal-title":"J. Immunother. Cancer"},{"issue":"24","key":"46830_CR75","doi-asserted-by":"publisher","first-page":"13521","DOI":"10.3390\/ijms222413521","volume":"22","author":"C Gentile","year":"2021","unstructured":"Gentile, C. et al. Generation of a retargeted oncolytic herpes virus encoding adenosine deaminase for tumor adenosine clearance. Int. J. Mol. Sci. 22(24), 13521 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"46830_CR76","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1080\/19420862.2018.1463945","volume":"10","author":"E Sasso","year":"2018","unstructured":"Sasso, E. et al. A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells. MAbs 10(5), 730\u2013737 (2018).","journal-title":"MAbs"},{"issue":"15","key":"46830_CR77","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M. et al. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30(15), 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"issue":"14","key":"46830_CR78","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25(14), 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"issue":"2","key":"46830_CR79","doi-asserted-by":"publisher","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10(2), giab008 (2021).","journal-title":"Gigascience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46830-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46830-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46830-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T14:04:16Z","timestamp":1699538656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46830-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46830-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19541"}}